These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10828260)

  • 1. Statistical analysis of skin tumor data from Tg.AC mouse bioassays.
    Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW
    Toxicol Sci; 2000 Jun; 55(2):293-302. PubMed ID: 10828260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.
    Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW
    Toxicol Pathol; 2001; 29 Suppl():51-9. PubMed ID: 11695562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.
    Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW
    Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.
    Trempus CS; Haseman JK; Tennant RW
    Mol Carcinog; 1997 Sep; 20(1):68-77. PubMed ID: 9328437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tg.AC genetically altered mouse: assay working group overview of available data.
    Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
    Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice.
    Nylander-French LA; French JE
    Toxicol Pathol; 1998; 26(4):476-83. PubMed ID: 9715506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.
    Holden HE; Stoll RE; Spalding JW; Tennant RW
    J Appl Toxicol; 1998; 18(1):19-24. PubMed ID: 9526830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.
    Sistare FD; Thompson KL; Honchel R; DeGeorge J
    Int J Toxicol; 2002; 21(1):65-79. PubMed ID: 11936901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.
    Doi AM; Hailey JR; Hejtmancik M; Toft JD; Vallant M; Chhabra RS
    Toxicol Pathol; 2005; 33(6):631-40. PubMed ID: 16176922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA; Spalding JW; French JE; Tennant RW
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse.
    Battalora MS; Spalding JW; Szczesniak CJ; Cape JE; Morris RJ; Trempus CS; Bortner CD; Lee BM; Tennant RW
    Carcinogenesis; 2001 Apr; 22(4):651-9. PubMed ID: 11285202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse.
    Trempus CS; Bishop WR; Njoroge FG; Doll RJ; Battalora MS; Mahler JF; Haseman JK; Tennant RW
    Mol Carcinog; 2000 Jan; 27(1):24-33. PubMed ID: 10642434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.
    Thompson KL; Rosenzweig BA; Honchel R; Cannon RE; Blanchard KT; Stoll RE; Sistare FD
    Mol Carcinog; 2001 Dec; 32(4):176-86. PubMed ID: 11746829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
    Hansen LA; Trempus CS; Mahler JF; Tennant RW
    Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene.
    Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE
    Toxicol Pathol; 1998; 26(4):541-7. PubMed ID: 9715513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.